Back | Next |
home / stock / torc / torc message board
Subject | By | Source | When |
---|---|---|---|
Will be trading above $4 once we get | andre1234 | investorshub | 06/18/2020 12:53:15 AM |
$torc current | Taurus69 | investorshub | 06/13/2020 9:57:34 PM |
$torc merger | Taurus69 | investorshub | 06/13/2020 9:57:15 PM |
$torc $5 with news | Taurus69 | investorshub | 06/13/2020 9:56:22 PM |
$torc $2.09 ^ 0.05 (2.45%) | Taurus69 | investorshub | 06/13/2020 9:54:44 PM |
$TORC will test $3.00 soon! Closing of merger | andre1234 | investorshub | 06/10/2020 1:53:10 AM |
$TORC Its ALIVE! | RLBLB | investorshub | 06/08/2020 5:48:37 PM |
Yep, I am | TTIME | investorshub | 06/08/2020 10:09:48 AM |
Are we still liking this? Still holding 4000 shares | D-bol | investorshub | 06/08/2020 12:24:07 AM |
Agreed. Just need to be patient with this | andre1234 | investorshub | 06/05/2020 11:54:29 PM |
$TORC, I see Great times ahead for us | TTIME | investorshub | 06/01/2020 6:09:38 AM |
Been holding here since 1.39. Adicet has legit | andre1234 | investorshub | 05/31/2020 1:22:34 PM |
$TORC NEWS !!, Monsta in the making my | TTIME | investorshub | 05/28/2020 12:29:02 PM |
$TORC, Good luck man, I added more to | TTIME | investorshub | 05/15/2020 5:56:32 AM |
Right or wrong I'm all out. | swingingRichard | investorshub | 05/14/2020 3:03:08 AM |
Nice little find here | Alexxdj1 | investorshub | 05/14/2020 1:39:53 AM |
$TORC merger partner ))))) - | TTIME | investorshub | 05/13/2020 9:28:46 PM |
Not many shares available, been getting gobbled | Rookiemove | investorshub | 05/13/2020 1:05:09 PM |
$TORC, easy imo for starters | TTIME | investorshub | 05/12/2020 8:29:58 PM |
I agree, it will be brief. | Rookiemove | investorshub | 05/12/2020 7:49:22 PM |
News, Short Squeeze, Breakout and More Instantly...
- Adicet Emerges as a Leading Allogeneic Gamma Delta T Cell Therapy Company Focused on Oncology - -Trading to Commence on September 16, 2020 on The Nasdaq Global Market Under Ticker Symbol “ACET”- MENLO PARK, Calif. and BOSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) -...
MENLO PARK, Calif. , Aug. 5, 2020 /PRNewswire/ -- Adicet Bio, Inc., a privately-held biopharmaceutical company, today announced that it has received a $10 million milestone payment from Regeneron associated with ADI-002 meeting key preclinical development goals, in accordance with the t...
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, today provided a corporate update and reported financial results ...